drug discovery

Featured

3D Systems Spins off Bioprinting Startup Systemic Bio

After venturing deeply into the bioprinting space, 3D Systems (NYSE: DDD) is shifting gears by spinning out its assets in this sector into a new, wholly owned company: Systemic Bio….

With $35M Bioprinting Investment Prellis Biologics Takes on New CEO

Organ bioprinting startup Prellis Biologics raised $35 million in a Series C round and plans to use the fresh capital to expand its proprietary, first-in-class human immune system-based drug discovery…

Cell Culture Startup to Tackle Heart Disease with Mitsubishi, Sumitomo and Toppan

Kyoto University spinout Myoridge was founded in 2016 as a bioventure, piggybacking on patented technology developed at the university’s Institute for Integrated Cell-Material Sciences (iCeMS). Since then, the company cultivates…

Featured

How this Medtech Startup Found a Niche Bioprinting Tumor Models

In the battle against a disease that kills roughly 26,000 people each day, the importance of greater speed in drug development is critical. In 2018, an estimated 9.5 million people…

Sydney Bioprinting Firm Closes $25M Series B Round

In a Series B round led by Australia’s largest venture capital (VC) firm, Blackbird Ventures, Sydney-headquartered biotech startup Inventia raised $25 million (A$35 million). The company also landed in the…

Bioprinting BICO Endorses FDA Modernization Act of 2021

The Swedish firm BICO, formerly CELLINK, has endorsed the FDA Modernization Act of 2021. Formally known as H.R. 2565/ S. 2952, the bill would replace major portions of the 1938…

BICO Granted Bioprinting Patents That “Improve Cell Viability and Reproducibility”

Leading biotechnology firm BICO has been issued two patents to help regulate and control temperature during the 3D bioprinting process. According to its inventors, they will allow for higher cell…

Featured

Cellink Expands its Bioconvergence Footprint in India

Bioconvergence company Cellink partnered with 3D printing technology supplier Altem Technologies to accelerate the groundwork for life-sciences bioprinting in the Indian market. Local research institutions and hospitals can now contact…

3D Printing News Briefs, June 9, 2021: CHAMPP, University of Minnesota, GE, Silca, ExOne & Celwise

First things first in this edition of 3D Printing News Briefs, Alloyed has received a hybrid AM research grant, and researchers from the University of Minnesota have developed a spherical…

Featured

What It Takes to Design a Bioprinter for Cancer Research, from Inventia Life Sciences

At a time when experts predict cancer will remain a massive health problem, advances in technology can make a big difference. Earlier this year, the World Health Organization (WHO) announced…

Keith Murphy: “We Believe We are Discovering the Next Step in Drug Development”

It’s been three years since Keith Murphy and Jeffrey Miner joined forces to create the biotechnology company Viscient Biosciences. In 2017, the co-founders had recently left their previous successful enterprises…

Biogelx in Brazil: New Collaboration for Research Tissue Bioprinting Inks

Throughout the years we have been following the success of startups that have originated from the academic field. Universities around the world foster the spirit of entrepreneurship by encouraging both…

Interview with Tamer Mohamed of Aspect Biosystems on Advancing Tissue Therapeutics

While attending The University of British Columbia (UBC), Tamer Mohamed, along with fellow graduate student Simon Beyer, began working at the Walus Laboratory on the development of a novel microfluidics-based…

regenHU and Wako Automation Promoting Drug Discovery and 3D Bioprinting in the US

Typically, the first thing that comes to mind for most people when they hear the term 3D bioprinting is fully 3D printed, working human organs. The thought of being able…